arrow
S

Sunil Iyengar

Royal Marsden Hospital
H指数:22
被引数:2,835

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up

奥加曲沙在瓦尔登斯特伦巨球蛋白血症中,5年随访显示持久应答

2026-04-170
OAAI
UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants

英国临床实践指南:针对携带体细胞POT1致病性变异患者的管理

2025-05-110
PRE
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications

Glofitamab和Epcoritamab在真实世界中的疗效、耐受性及实际意义:一项英国多中心回顾性分析

BLOOD
IF23.1
2024-11-051
PRE
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis
2024-06-133
OAAI
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
LEUKEMIA
IF13.4
2024-06-084
OAAI
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy
2024-05-212
OAAI
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

慢性淋巴细胞白血病患者新型冠状病毒肺炎和COVID后病情的演变: 欧洲CLL研究计划ERIC的一项研究

2023-09-2911
OAAI
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

BTK和PLCG2在接受依鲁替尼治疗的CLL复发患者的3分之1中保持未突变

2023-06-1638
OAAI
A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications
2023-04-186
OAAI
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
2022-12-1313
OAAI
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study
2022-06-285
OAAI
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
2021-10-27130
OAAI